Quick answer
Men most often search for peptides around four goals: muscle, weight, libido and hair. Only the weight-loss drugs are approved and proven for their use. Crucially, no peptide is testosterone replacement — testosterone is a steroid hormone, not a peptide, and the two are different classes of molecule.
Muscle & performance
This is the biggest draw, and the one with the weakest evidence. Growth-hormone secretagogues (ipamorelin, CJC-1295, GHRP-6) and IGF-pathway compounds are popular in gyms, but none is proven to build muscle in humans, and all growth-hormone-releasing peptides are banned in sport by WADA. See peptides for muscle growth and peptides for bodybuilding.
Important: the popular muscle peptide MK-677 is not actually a peptide — it's a small molecule. See is MK-677 a peptide?
Weight loss
The GLP-1 and dual-agonist drugs (semaglutide, tirzepatide) are FDA-approved, trial-proven weight-loss medicines used widely by men. Unlike the muscle peptides, these genuinely work. See peptides for weight loss.
Libido & sexual health
PT-141 (bremelanotide) acts on brain melanocortin pathways involved in sexual desire — a different mechanism from erectile blood-flow drugs like Viagra. It's FDA-approved for low sexual desire in premenopausal women; its use in men is off-label and less established. Note that testosterone is not a peptide (it's a steroid hormone), so it's outside this site's scope.
Hair
For thinning hair, copper peptides and others come up — covered in our dedicated peptides for hair guide. The honest summary: promising but unproven, and no peptide matches the evidence behind minoxidil or finasteride.
Peptides are not testosterone replacement
This is the most common and most consequential confusion in the "peptides for men" space, so it is worth being explicit.
Testosterone is a steroid hormone, not a peptide. It is a small lipid-soluble molecule built from cholesterol, and it works by entering cells and acting on receptors inside them. Peptides are chains of amino acids that act on receptors on the cell surface. They are different classes of molecule entirely, and a peptide cannot substitute for testosterone replacement therapy.
The confusion arises because some peptides act on the same hormonal axis. Gonadorelin and kisspeptin act upstream on the signalling that tells the testes to produce testosterone, and are used clinically in fertility and diagnostic contexts. That is a genuinely different thing from supplying testosterone, and it depends on the axis being intact and responsive in the first place.
Similarly, growth hormone secretagogues such as ipamorelin and CJC-1295 act on growth hormone, not testosterone. They are frequently marketed to men in language that blurs the two, but growth hormone and testosterone are separate systems with separate effects.
Anyone actually concerned about low testosterone needs a diagnosis and a clinician, not a research peptide. Symptoms attributed to low testosterone are frequently caused by something else, and the only way to know is to measure.
The questions men actually ask
A few recurring questions come up often enough to be worth answering directly.
Will peptides build muscle without training? No. Growth hormone secretagogues raise growth hormone and IGF-1, but the human evidence that this translates into meaningful strength or lean-mass gains in healthy adults is weak, and nothing substitutes for training and adequate protein. Growth hormone itself, which is far more potent than any secretagogue, has a notably unimpressive record for strength gains in healthy people.
Are peptides safer than steroids? Not a question with a clean answer. Anabolic steroids have well-documented risks; unapproved peptides have largely undocumented ones. Unknown risk is not the same as low risk, and the comparison is often made in a way that implies otherwise. See peptides vs steroids for the detail.
Do peptides help with erectile dysfunction? PT-141 (bremelanotide) is an approved peptide medicine, but it is approved for low sexual desire in premenopausal women, not for erectile dysfunction in men. It acts on desire pathways in the brain rather than on blood flow, which is what the established ED medications target.
Will peptides regrow hair? The evidence is limited and mostly topical and cosmetic. See peptides for hair for what has actually been studied.
The honest framing
The pattern for men mirrors the whole field: the weight-loss peptides are approved and proven, while the muscle and recovery peptides most associated with men are unapproved research chemicals with little human evidence and sport bans. Popularity in the gym is not proof. See are peptides safe? and do peptides actually work?
Frequently asked questions
What are the best peptides for men?
It depends on the goal. For weight, the FDA-approved GLP-1 drugs (semaglutide, tirzepatide). For muscle, growth-hormone secretagogues like ipamorelin and CJC-1295 are popular but unproven in humans and banned in sport. For libido, PT-141. Peptides otherwise work the same regardless of sex.
What peptides are best for muscle growth in men?
The commonly used ones are growth-hormone secretagogues (ipamorelin, CJC-1295, GHRP-6) and IGF-pathway compounds, but none is proven to build muscle in humans and all are banned in sport. The popular 'MK-677' is not even a peptide — it's a small molecule.
Is there a peptide for male libido?
PT-141 (bremelanotide) acts on brain pathways involved in sexual desire. It's FDA-approved for low desire in premenopausal women; use in men is off-label and less established. Testosterone is not a peptide, so it's outside this reference's scope.
Are peptides safe for men?
The approved peptide medicines have known safety profiles used under supervision. The muscle and recovery research peptides most marketed to men are unapproved, unproven in humans, and carry the quality risks of unregulated products, plus sport bans.
Further reading
Selected peer-reviewed sources on this topic, labelled by type. A citation is a reference, not an endorsement.
- Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022. Peer-reviewed study
- Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021. Peer-reviewed study